digital currency the future of money People searches

Zhengzhou Investment Holding Company increased its capital to 7.78 billion yuan, with an increase of about 121%. Tianyancha App shows that Zhengzhou Investment Holding Co., Ltd. has undergone industrial and commercial changes recently, adding Zhengzhou Development Investment Group Co., Ltd. as a shareholder, and its registered capital has increased from about 3.53 billion yuan to about 7.78 billion yuan, with an increase of about 121%. At the same time, many senior executives have changed. Zhengzhou Investment Holding Co., Ltd. was established in October 2005, and its legal representative is Yu Jianwei. Its business scope covers state-owned assets investment and management, real estate development and sales, and house leasing. Now Zhengzhou Zhongrongchuang Industrial Investment Co., Ltd. and the above-mentioned newly-added shareholders jointly hold shares.FTSE China A50 index futures fell 2%.CITIC Jiantou: It maintains the "Buy" rating of Orrit, and its product line continues to expand and enrich. According to the research report of CITIC Jiantou Securities, Orrit (605116.SH) is one of the leading companies in the field of characteristic APIs in China. In recent years, the company's product line has been continuously expanded and enriched, which has promoted the continuous growth of revenue. At the same time, the company actively laid out potential areas, and at the current point of time, we think that we can see the company's follow-up multiple catalysis: 1) The preparation business continues to be heavy: the market development of diqu progesterone tablets continues to advance, and the estradiol/estradiol-diqu progesterone composite packaging tablets have been declared for listing. It is expected that the continuous enrichment of new pipelines for the follow-up preparation business will promote the company's performance growth. 2) Smegrutide API: The construction of fermentation workshop and synthesis workshop has been completed, and the expansion and release of new capacity will promote the good growth of API business. 3) Small nucleic acid business: The 100 kg commercial production line landed in September, 2004, opening up the space for subsequent growth. Maintain the "buy" rating.

Vegetable oil fell by 1.90% on the 13th, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract vegetable oil closed at 2,505, up or down by -1.90%, with a turnover of 535,800 lots. The position data showed that the top 20 seats were clear, and the difference position was 21,545 lots. The total turnover of vegetable oil futures contracts was 593,700 lots, a decrease of 112,100 lots from the previous day. The first 20 seats in the contract held 232,900 lots, a decrease of 3,819 lots from the previous day. The short positions in the top 20 seats of the contract were 254,200 lots, an increase of 687 lots over the previous day. (Sina Futures)Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.Stock index futures continued to fall, and the main contract of SSE 50 Stock Index Futures (IH) fell by 2.00% in the day, and now it is reported at 2,653.6 points. The main contract of CSI 500 stock index futures (IC) fell by 2.00% in the day and is now reported at 5976.8 points.

Citigroup: The target price of Illumina is lowered from $190 to $165, and the rating is lowered from "buy" to "neutral".Anhui procuratorate prosecuted Huawei Yu, the former deputy general manager of Anhui Investment Group Holding Co., Ltd., for allegedly accepting bribes. According to the highest inspection news, a few days ago, Huawei Yu, the former party member and deputy general manager of Anhui Investment Group Holding Co., Ltd., was suspected of accepting bribes, and the Huainan Municipal People's Procuratorate filed a public prosecution with the Huainan Intermediate People's Court according to law after the jurisdiction designated by the Anhui Provincial People's Procuratorate. The case is being further processed. At the stage of examination and prosecution, the procuratorial organ informed the defendant Huawei Yu of his litigation rights according to law, interrogated the defendant according to law and listened to the opinions of defenders. The People's Procuratorate of Huainan City charged that the defendant Huawei Yu, as a national staff member, used the convenience of his position and the convenience of his authority or position to seek benefits for others through the actions of other national staff members, and illegally accepted other people's property alone or in collusion with others. The amount was extremely huge, so he should be investigated for criminal responsibility for accepting bribes according to law.Jimi Technology: The wholly-owned subsidiary has received the designated notice of development from a well-known domestic automobile main engine factory, and Jimi Technology announced that Yibin Jimi, a wholly-owned subsidiary, has received the designated notice of development from a well-known domestic automobile main engine factory, and will become the designated development supplier of the customer's car projector to supply intelligent cockpit display products.